Expect Ocrevus To Drive Roche Holding's Q3 Earnings Growth

Get the Full StoryRoche Holding NASDAQ:RHHBY is scheduled to announce its Q3 earnings on October 17. We expect mid-single digit growth in the company s top line, primarily led by Ocrevus, which has seen strong growth in the recent past. However, Oncology drugs revenue growth could remain tepid, as growth in...

Share: